Australian biotherapeutics company CSL has reached an agreement with Chinese healthcare company Humanwell Healthcare Group to acquire an 80% equity stake in the latter’s subsidiary, Wuhan Zhong Yuan Rui De Biological Products (Ruide).
The acquisition is to be funded through CSL’s existing debt facilities and also includes milestone-based performance and payment mechanism to increase the stake further.
Go deeper with GlobalData
The purchase consideration for the acquisition is $352m.
Chinese pharmaceutical company Sunflower Pharmaceutical Group has acquired 10% stake in a pharmaceutical unit based in Xiangyang.
The purchase consideration for the acquisition involved approximately three million shares of the target company and totalled CNY40.33m ($5.94m).
See Also:
Immunotech Laboratories, a drug development company based in the US, has been acquired by US-based oil and gas company, Eco-Petroleum Solutions.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe stock transaction will result in an opportunity to bring a new immunotherapy to Europe and innovate HIV / AIDS treatments.
